Financials
Overview
Mdxhealth operates on a calendar basis with its accounting year ending on Dec. 31. The company reports its consolidated financial statements under International Financial Reporting Standards (IFRS) and all amounts are in US Dollars. Mdxhealth publishes a consolidated and audited Annual Report on an annual basis, a consolidated Interim Report for its June 30 half-year financial figures, and business/financial updates at the end of Q1 and Q3.
Furthermore, for the Annual General Shareholders’ Meeting, the company also publishes the non-consolidated Belgian-GAAP financial statements of the parent company. Prior to October 5, 2010, mdxhealth operated under the name OncoMethylome Sciences.
Financial Reports
2022
2022 Interim Report for the six months ended June 30, 2022: English I Français
2023 Interim Report for the nine months ended September 30, 2022: English
2022 Consolidated Figures: English
2021
2021 Interim Report: English I Français
2021 Consolidated Figures: English
2021 Board Report on Financial Statements: English I Français
2021 Full Non-consolidated Statutory Accounts: Français
2021 Annual Report (PDF): English I Français
2021 Annual Report (XBRL ZIP): English | Français I View XBRL
2020
2020 Interim Report: English I Français
2020 Consolidated Figures: English
2020 Board Report on Financial Statements: English I Français
2020 Full Non-consolidated Statutory Accounts: Français
2019
2019 Interim Report: English | Français
2019 Consolidated Figures: English
2019 Board Report on Financial Statements: English I Français
2019 Full Non-consolidated Statutory Accounts: Français
2018
2018 Interim Report: English | Français
2018 Consolidated Figures: English
2018 Board Report: English
2018 Full non consolidated statutory Accounts: Français
2017
2017 Annual Report “after correction to take into account a clerical drafting error”: english | français
Full year 2017 Non Consolidated Statutory Account: français
Auditors Opinion: english | français
Board Report on 2017 Financial Statements “after correction to take into account a clerical drafting error”: english | français
2017 Consolidated figures: english
2016
2016 Annual Report: english | français
Full year 2016 Non Consolidated Statutory Account : français
Auditors Opinion: english
Board Report on 2016 Financial Statements: english | français
2016 Interim report : english | français
2016 Consolidated figures: english
2015
2015 Interim report : english | français
2015 Consolidated Statement of Comprehensive Income: english
2015 Annual Report: english | français
Full Year 2015 Non Consolidated Statutory Accounts: français
2014
Full Annual Report: english | français
2014 Consolidated Statements: english
Full Year 2014 Non Consolidated Statutory Accounts: français
2013
2013 Interim Report: english | français
Full Annual Report: english | français
New full year 2013 non-consolidated statement account: français
Auditor’s opinion: english | français
Full year 2013 non-consolidated statutory accounts: français
Consolidated Financial Statements 2013: english
2012
Full year 2012 Registration Document (Annual Report): English | Français
2012 Auditor’s opinion: English | Français
Full year 2012 non-consolidated statutory accounts: Français
2012 Interim Report: English | Français
Consolidated Financial Statements 2012: English
Special Reports
The financial service for the shares of the company is provided in Belgium by KBC. Shareholders should inform themselves about the costs that other financial intermediaries may charge in connection with paying agency services.
Investor Relations Contact
For all investor related questions please call or email:
LifeSci Advisor (PR & IR)
US: +1.949.271.9223
ir@mdxhealth.com
